Factor XIII Val34Leu polymorphism does not affect the risk for thrombotic complications in patients with antiphospholipid syndrome.
Author
Hancer, VS
Inanc, Murat
Nalcaci, M
Pekcelen, Y
Diz-Kucukkaya, R
Metadata
Show full item recordCollections
- Bildiri [64839]